Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

The "Big 3 Stack" for hair loss treatment, which includes Minoxidil for hair density improvement, Ketoconazole shampoo for enhancing hair volume and thickness, and Finasteride for blocking hair loss causing hormones. Microneedling can boost Minoxidil's effects.

The user switched to Cimed's finasteride, noticing reduced hair shedding and improved hair density, while also managing anxiety with sertraline and taking vitamins. They experienced a temporary decrease in libido after increasing the finasteride dose but observed thicker eyebrows and plan to update on progress in six months.

The user has been using topical minoxidil for over a year and finasteride for 2.5 years, seeing some progress but still experiencing thinning at the crown. Suggestions include continuing with current treatments, considering oral minoxidil, adding dermastamping, and possibly a hair transplant if desired results are not achieved.

A 35-year-old male used oral finasteride and topical minoxidil, later transitioning to oral minoxidil, to stop hair loss and improve hair density. He plans a future hair transplant and experienced temporary libido changes but no permanent side effects.

A 22-year-old male experienced progress with 0.5 mg daily finasteride for hair loss but noticed recent shedding, which may be a synchronized shed. Users suggest continuing the current dose, considering increasing to 1 mg, or exploring additional treatments like GHK-cu, while noting that watery semen is a common side effect.

The user has been using topical finasteride and minoxidil for 6 months to address hair loss and is seeking opinions on their progress and potential need for a hair transplant. They have noticed significant improvement in hair density, especially in the front, and are considering using 2,500 grafts for a transplant while evaluating their donor area and future hair loss potential.

Breezula is seen as a potential future treatment for hair loss, but its release is uncertain and current data is limited. Other treatments like GT20026 and pyrilutamide are discussed, but skepticism remains about their effectiveness compared to established options like finasteride and minoxidil.

A 22-year-old started taking finasteride at 20 to combat hair loss, experiencing significant shedding initially but no side effects. Despite challenges in obtaining dutasteride and oral minoxidil in Sweden, the user is content with the current hairline and considering additional treatments like microneedling.

The user is 55 days post-hair transplant with 2163 grafts, using treatments like Dutasteride, oral Minoxidil, Biotin, and GHK-Cu peptide. They are seeking opinions on their progress, particularly regarding density and normalcy for day 55.

The user has been using a combination of treatments including Dutasteride, Minoxidil, RU58841, ketoconazole shampoo, microneedling, and low-level laser therapy to address hair loss but continues to experience shedding and density loss. Despite high testosterone and iron levels, the user is frustrated with the lack of improvement and is considering adjusting treatment or exploring other options like a hair transplant.

PP405 is discussed as a potential treatment for hair loss, with excitement about its promise but skepticism about its current effectiveness. Users mention combining it with treatments like minoxidil, finasteride, and microneedling, but emphasize it is not a cure.

PP405 is discussed as a potential adjunct therapy for hair loss, with skepticism about its effectiveness and trial results. Users mention combining it with finasteride and minoxidil for better results, while others debate the root causes of hair loss and the limitations of current treatments.

The user has been using oral Minoxidil and finasteride for a year, experiencing stronger and healthier hair with hope for further improvement. Many suggest a haircut to enhance appearance, while others encourage continuing the current regimen and possibly adding micro-needling.

The user has been using topical finasteride (0.1%) and minoxidil (5%) for over 8 months, experiencing significant hair shedding and loss of density, and is considering switching to topical dutasteride. They are hesitant to switch due to potential shedding but plan to wait until the 12-month mark before making a decision.

A 29-year-old male is using alcohol-based 5% topical minoxidil, oral minoxidil 2.5 mg daily, and dermarolling to address hair loss, after discontinuing topical finasteride due to sexual side effects. He notices improved hair quality and thickness but is concerned about density and seeks feedback on his progress.

The user shared their progress using finasteride and minoxidil for hair loss, noting initial side effects and improved hair density. They experienced shedding but saw better results after increasing the finasteride dose and undergoing a hair transplant.

A 19-year-old has been using a regimen of 5% topical minoxidil and 1mg oral finasteride for three months to combat early-onset balding. The user reports some progress and plans to continue the current treatment, while others suggest considering additional treatments like dutasteride for more aggressive cases.

A user is treating hair loss with 0.5mg Dutasteride three times a week, 5mg oral Minoxidil daily, and topical finasteride and minoxidil, seeing some improvement but insufficient density. They are considering increasing Dutasteride dosage and addressing high estradiol levels, while also trying to quit vaping.

The user shared their hair loss journey, using Minoxidil 2%, Serenoa repens, topical finasteride, a topical antiandrogen, Vitamin D, and lifestyle changes, noting improvements but still seeking more density. They are considering switching to Minoxidil 5% but prefer focusing on finasteride and antiandrogen for better results.

Minoxidil and finasteride work through different mechanisms; minoxidil-dependent hair requires continued use to maintain growth, while finasteride prevents further hair loss but cannot sustain minoxidil gains alone. Current treatments like minoxidil, finasteride, and others need indefinite use, as no permanent solution exists yet.

The user shares a positive experience with Dutasteride for hair loss, noting increased hair density and minimal side effects after switching from Finasteride. They prefer oral Dutasteride and avoid Minoxidil due to its inconvenience and potential risks.

The user has been taking 1mg of finasteride daily for a year, maintaining hair density without regrowth. They are considering oral minoxidil for regrowth, avoiding topical minoxidil due to its toxicity to cats, despite concerns about heart side effects.

New hair loss treatments include Breezula, PP405, ET-02, KX-826, GT20029, VDPHL01, and CosmeRNA, with some showing promise in reactivating stem cells and reversing greying. Breezula and VDPHL01 are highlighted as potential add-ons or alternatives to current treatments like finasteride and minoxidil.

The user is experiencing increased hair thinning and shedding despite using oral dutasteride, oral minoxidil, topical dutasteride, and ketoconazole shampoo. Many recommend considering a hair transplant or embracing baldness, as current treatments seem ineffective.

A 19-year-old shares positive results after one year on finasteride, minoxidil, micro-needling, and Nizoral shampoo, reporting no side effects and improved hair density despite initial shedding. Others discuss mixed experiences with finasteride, some considering alternatives like dutasteride or hair transplants.

A user successfully regrew hair over 20 months using oral dutasteride and minoxidil, with no significant side effects. They are satisfied with the results but may consider a hair transplant for more density.

PP405 is a potential hair loss treatment showing promising early results, with hopes for market release by 2028, but skepticism remains due to inconclusive data and past disappointments with similar products. Current treatments like Minoxidil and Finasteride have side effects, leading some to anticipate PP405 as a safer alternative, though its effectiveness compared to placebo is debated.

Increased hair shedding after starting Dutasteride is normal and indicates treatment efficacy, as it triggers a synchronized shedding phase to make way for stronger hair growth. It is advised to continue with the current treatment plan and assess results in 9 to 12 months.

PP405 shows potential for hair growth, with 31% of advanced balding men experiencing over 20% increase in hair density in 8 weeks. However, skepticism persists due to selective data presentation and lack of long-term results, with comparisons to treatments like minoxidil and finasteride.

PP405 shows promise in treating severe hair loss, with 31% of users experiencing over 20% hair density increase in four weeks, faster than minoxidil and finasteride. Some users are skeptical about the results' significance and long-term efficacy.